Regulation of NMDA receptor trafficking by amyloid-β
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This synaptotoxicity is associated with a reduction in the surface expression of various receptor proteins, including those forming the N-methyl-D-aspartate receptors [26,27], which are critical for generation of long-term potentiation in hippocampal synapses.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“Oligomeric Aβ species have been shown to cause memory deficits in rodents [25] and are known for their synaptotoxic properties.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines 47,48 and reduces expression of NMDARs and related synaptic proteins, 49 through several signaling pathways, one of which involves the a-7 nicotinic receptor.49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“Indeed Aβ production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57], [58].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [57]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Results Amyloid-β decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-β regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor current”
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Cited by
Items 101–200 of 1,006
Calcium signaling and molecular mechanisms underlying neurodegenerative diseases
Pchitskaya, E., Popugaeva, E., & Bezprozvanny, I. (2018) · Cell Calcium · doi:10.1016/j.ceca.2017.06.008 · Cited by 349
“Another adverse effect of Aβ is a reduction in NMDAR expression and its enhanced endocytosis (Snyder et al., 2005).”
Implications of peptide assemblies in amyloid diseases
Ke, P. C., Sani, M.-A., Ding, F., Kakinen, A., Javed, I., Separovic, F., Davis, T. P., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00372b · Cited by 338
Williams, T. L., & Serpell, L. C. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08228.x · Cited by 335
Kimura, R., & Ohno, M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.006 · Cited by 333
“, 2005) or the NMDA receptor subunits NR1 and NR2B (Dewachter et al., 2008; Snyder et al., 2005) in APP mouse neurons provide a molecular basis for these physiological changes, although precise mechanisms by which Aβ accumulation alters synapses remain to be determined.”
BackgroundSoluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases
Ferreira, S. T., Vieira, M. N. N., & De Felice, F. G. (2007) · IUBMB Life · doi:10.1080/15216540701283882 · Cited by 335
Protein tyrosine phosphatases as potential therapeutic targets
He, R.-J., Yu, Z.-H., Zhang, R.-Y., & Zhang, Z.-Y. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.80 · Cited by 327
Muscle and neuronal nicotinic acetylcholine receptors: Structure, function and pathogenicity
Kalamida, D., Poulas, K., Avramopoulou, V., Fostieri, E., Lagoumintzis, G., Lazaridis, K., Sideri, A., Zouridakis, M., & Tzartos, S. J. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05935.x · Cited by 333
Alzheimer’s disease and insulin resistance: translating basic science into clinical applications
De Felice, F. G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64595 · Cited by 330
Raymond, L. A., André, V. M., Cepeda, C., Gladding, C. M., Milnerwood, A. J., & Levine, M. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.052 · Cited by 325
“, 2006), the STriatal Enriched tyrosine Phosphatase (STEP) dephosphorylates the GluN2B tyrosine 1472 residue, leading to reduced synaptic NMDAR expression (Pelkey et al., 2002; Prybylowski et al., 2005; Snyder et al., 2005; Braithwaite et al., 2006).”
Targeting NMDA receptors in stroke: new hope in neuroprotection
Wu, Q. J., & Tymianski, M. (2018) · Molecular Brain · doi:10.1186/s13041-018-0357-8 · Cited by 319
“In mature neurons, GluN2A-containing NMDARs are abundant in the synapses, and GluN2B-containing NMDARs are enriched in the extrasynaptic sites.”
InfluentialSoluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway
Townsend, M., Mehta, T., & Selkoe, D. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610390200 · Cited by 318
Almeida, C. G., Takahashi, R. H., & Gouras, G. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5078-05.2006 · Cited by 316
Self-citationChin, J., Palop, J. J., Puoliväli, J., Massaro, C., Bien-Ly, N., Gerstein, H., Scearce-Levie, K., Masliah, E., & Mucke, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2980-05.2005 · Cited by 312
The role of CREB signaling in Alzheimer’s disease and other cognitive disorders
Saura, C. A., & Valero, J. (2011) · revneuro · doi:10.1515/rns.2011.018 · Cited by 312
Zhang, S.-J., Zou, M., Lu, L., Lau, D., Ditzel, D. A. W., Delucinge-Vivier, C., Aso, Y., Descombes, P., & Bading, H. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000604 · Cited by 309
Alzheimer's disease: synapses gone cold
Koffie, R. M., Hyman, B. T., & Spires-Jones, T. L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-63 · Cited by 308
“Indeed, Ab-mediated internalization of AMPA [85] and NMDA receptors [81], loss of dendritic”
Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000562 · Cited by 308
“A , through 7 nAChRs, increases Ca2 , which phosphorylates NMDARs via calcineurin and protein tyrosine phosphatase, nonreceptor type 5 (striatum-enriched) (Snyder et al., 2005).”
Synaptic changes in Alzheimer’s disease and its models
Pozueta, J., Lefort, R., & Shelanski, M. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.050 · Cited by 307
Calcium ions in neuronal degeneration
Wojda, U., Salinska, E., & Kuznicki, J. (2008) · IUBMB Life · doi:10.1002/iub.91 · Cited by 301
“Mutant Ht was shown to interfere with the binding of NMDARs to the post- synaptic density protein PSD-95, leading to NMDAR hypersensitivity and an increase in Ca21 influx (108–110).”
InfluentialNeurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
Xu, Y., Yan, J., Zhou, P., Li, J., Gao, H., Xia, Y., & Wang, Q. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.002 · Cited by 301
“confirmed enhanced endocytosis of NMDA receptors by Ab in AD (Snyder et al., 2005).”
Endoplasmic Reticulum–Plasma Membrane Contact Sites
Saheki, Y., & De Camilli, P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044932 · Cited by 297
Richard, K. L., Filali, M., Préfontaine, P., & Rivest, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1146-08.2008 · Cited by 298
“, 2004), and A induces NMDA receptor endocytosis of cultured cortical neurons (Snyder et al., 2005).”
Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease
Knobloch, M., & Mansuy, I. M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8018-z · Cited by 296
“inhibitors FK506 and cyclosporin can restore or prevent Aβ oligomer-mediated effects [60, 61, 64, 74].”
InfluentialAlzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
Rosales‐Corral, S. A., Acuña‐Castroviejo, D., Coto‐Montes, A., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00937.x · Cited by 294
Revett, T. J., Baker, G. B., Jhamandas, J., & Kar, S. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110190 · Cited by 292
Aberrant insulin signaling in Alzheimer's disease: current knowledge
Bedse, G., Di Domenico, F., Serviddio, G., & Cassano, T. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00204 · Cited by 292
“In the following section we will discuss the evidence of relation of insulin signaling deficiency with AD pathology and disease progression.”
BackgroundResultZempel, H., Luedtke, J., Kumar, Y., Biernat, J., Dawson, H., Mandelkow, E., & Mandelkow, E. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.207 · Cited by 283
“This is indeed the case, since blockage of both global and Tau protein synthesis strongly reduces dendritic missorting of Tau after A b O exposure.”
InfluentialRAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction
Takuma, K., Fang, F., Zhang, W., Yan, S., Fukuzaki, E., Du, H., Sosunov, A., McKhann, G., Funatsu, Y., Nakamichi, N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905686106 · Cited by 290
“Recent studies demonstrate that several plasma membrane receptors, such as N-methyl-D-aspartate receptors (14), 7 nicotinic acetylcholine receptors (15), and low-density lipoprotein receptor-related proteins (LRP) (16), have the capacity to bind to A and, potentially, promote intracellular accumulation of A .”
BackgroundDysfunction of NMDA receptors in Alzheimer’s disease
Zhang, Y., Li, P., Feng, J., & Wu, M. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2546-5 · Cited by 282
“When applied to cultured cortical neurons, Ab enhances endocytosis of NMDARs and decreases expression of NMDARs [53].”
Shelat, P. B., Chalimoniuk, M., Wang, J., Strosznajder, J. B., Lee, J. C., Sun, A. Y., Simonyi, A., & Sun, G. Y. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05347.x · Cited by 283
Presenilins are essential for regulating neurotransmitter release
Zhang, C., Wu, B., Beglopoulos, V., Wines-Samuelson, M., Zhang, D., Dragatsis, I., Südhof, T. C., & Shen, J. (2009) · Nature · doi:10.1038/nature08177 · Cited by 278
Xu, J., Kurup, P., Zhang, Y., Goebel-Goody, S. M., Wu, P. H., Hawasli, A. H., Baum, M. L., Bibb, J. A., & Lombroso, P. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2212-09.2009 · Cited by 280
“DOI:10.1523/JNEUROSCI.2212-09.2009 Copyright © 2009 Society for Neuroscience 0270-6474/09/299330-14$15.00/0 9330 • The Journal of Neuroscience, July 22, 2009 • 29(29):9330 –9343 ternalization of the NR1/NR2B receptor complex (Snyder et al., 2005).”
InfluentialSelf-citationRoselli, F., Tirard, M., Lu, J., Hutzler, P., Lamberti, P., Livrea, P., Morabito, M., & Almeida, O. F. X. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3034-05.2005 · Cited by 277
Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
Joshi, P., Turola, E., Ruiz, A., Bergami, A., Libera, D. D., Benussi, L., Giussani, P., Magnani, G., Comi, G., Legname, G., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.180 · Cited by 275
Metabotropic glutamate receptors and neurodegenerative diseases
Ribeiro, F. M., Vieira, L. B., Pires, R. G. W., Olmo, R. P., & Ferguson, S. S. G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.013 · Cited by 269
Mg2+Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Kotermanski, S. E., & Johnson, J. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3703-08.2009 · Cited by 271
“The clinical utility of memantine may be enhanced by its inhibition of -7 nAChRs [reported memantine IC50 ranges from 0.34 (Aracava et al., 2005) to 5 M (Maskell et al., 2003)], receptors that participate in amyloid- - induced NMDAR internalization (Snyder et al., 2005).”
InfluentialLiu, Q., Trotter, J., Zhang, J., Peters, M. M., Cheng, H., Bao, J., Han, X., Weeber, E. J., & Bu, G. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4067-10.2010 · Cited by 268
“Disruptions of ion currents in the postsynaptic glutamate receptor result in part from the loss of surface NMDA receptors (Snyder et al., 2005) or AMPA receptors (Hsieh et al., 2006).”
Neuronal hyperactivity--A key defect in Alzheimer’s disease?
Busche, M. A., & Konnerth, A. (2015) · BioEssays · doi:10.1002/bies.201500004 · Cited by 266
Models of β-amyloid induced Tau-pathology: The long and “folded” road to understand the mechanism
Stancu, I.-C., Vasconcelos, B., Terwel, D., & Dewachter, I. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-51 · Cited by 256
“Several studies have indicated downstream effects of amyloid peptides on NMDA-receptor function [95,97,98].”
Amyloid-β Receptors: The Good, the Bad, and the Prion Protein
Jarosz-Griffiths, H. H., Noble, E., Rushworth, J. V., & Hooper, N. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.702704 · Cited by 256
Diabetes and Alzheimer’s disease crosstalk
Baglietto-Vargas, D., Shi, J., Yaeger, D. M., Ager, R., & LaFerla, F. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.005 · Cited by 256
Ono, K., Li, L., Takamura, Y., Yoshiike, Y., Zhu, L., Han, F., Mao, X., Ikeda, T., Takasaki, J.-I., Nishijo, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.325456 · Cited by 251
Caccamo, A., Maldonado, M. A., Bokov, A. F., Majumder, S., & Oddo, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012851108 · Cited by 249
“NMDA receptors are fundamental for synaptic plasticity and long-term potentiation, and in this context, Aβ accumulation has been shown to reduce glutamatergic transmission and to inhibit synaptic plasticity by interfering with NMDA receptor endocytosis, thereby reducing the receptors’ availability at synapses (3, 4).”
InfluentialAmyloid-β as a Modulator of Synaptic Plasticity
Parihar, M. S., & Brewer, G. J. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101020 · Cited by 247
“appear to bind to NMDARs at the synapse [74] and induce internalization of NMDAR [75] and deregula-”
InfluentialPrion protein and Aβ‐related synaptic toxicity impairment
Calella, A. M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., Mansuy, I. M., & Aguzzi, A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000082 · Cited by 242
“PrPC concentration was determined by sandwich ELISA as described (Polymenidou et al, 2008).”
InfluentialNMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation
Amadoro, G., Ciotti, M. T., Costanzi, M., Cestari, V., Calissano, P., & Canu, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511065103 · Cited by 243
Different Routes of Bone Morphogenic Protein (BMP) Receptor Endocytosis Influence BMP Signaling
Hartung, A., Bitton-Worms, K., Rechtman, M. M., Wenzel, V., Boergermann, J. H., Hassel, S., Henis, Y. I., & Knaus, P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00022-06 · Cited by 243
“, it controls the level of receptors at the cell surface (16, 66).”
You, H., Tsutsui, S., Hameed, S., Kannanayakal, T. J., Chen, L., Xia, P., Engbers, J. D. T., Lipton, S. A., Stys, P. K., & Zamponi, G. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110789109 · Cited by 243
“Given that Aβ can regulate NMDA receptors (18), we studied the mechanistic relationship between Aβ, NMDA receptors, and PrP.”
Involvement of p38 MAPK in Synaptic Function and Dysfunction
Falcicchia, C., Tozzi, F., Arancio, O., Watterson, D. M., & Origlia, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165624 · Cited by 241
“It has been shown that higher Aβ levels are also able to depress glutamatergic synaptic transmission and surface receptor number [65].”
BackgroundExtracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
Rahman, M. M., & Lendel, C. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00465-0 · Cited by 239
Kelly, B. L., & Ferreira, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605081200 · Cited by 241
The NMDA receptor as a target for cognitive enhancement
Collingridge, G. L., Volianskis, A., Bannister, N., France, G., Hanna, L., Mercier, M., Tidball, P., Fang, G., Irvine, M. W., Costa, B. M., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.051 · Cited by 239
“Furthermore, synaptic and extrasynaptic NMDARs are differentially phosphorylated at GluN2B-Y1472 and GluN2B-Y1336, respectively (Goebel-Goody et al., 2009), suggesting that modulation of NMDAR tyrosine phosphorylation affects receptor retention and translocation between synaptic and extrasynaptic sites (Gladding and R…”
InfluentialMolecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Masters, C. L., Cappai, R., Barnham, K. J., & Villemagne, V. L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03989.x · Cited by 241
“…endocytosis of the NMDA receptor (mediated in part through a7 nicotinic ACh receptor [nAChR], protein phosphatase PP2B and tyrosine phosphase STEP (Snyder et al. 2005)), the findings on the beneficial behavioral effects of memantine in both Ab toxicity models (Yamada et al. 2005) and amyloid…”
BackgroundMorris, G. P., Clark, I. A., Zinn, R., & Vissel, B. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.07.002 · Cited by 236
“LTD can also be dependent on metabotropic type glutamate receptor (mGluR) activation (Snyder et al., 2005; Xiao, Zhou, & Nicoll, 2001).”
Kocahan, S., & Doğan, Z. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.1.1 · Cited by 233
Nakajima, A., & Ohizumi, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143380 · Cited by 235
Metabotropic Glutamate Receptor-Mediated Long-Term Depression: Molecular Mechanisms
Gladding, C. M., Fitzjohn, S. M., & Molnár, E. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001735 · Cited by 233
“It is noteworthy that it has been shown that STEP activity is increased in transgenic mouse models of Alzheimer’s disease (Chin et al., 2005; Snyder et al., 2005), raising the possibility that mGluR-LTD may be abnormal in these mice, although this has yet to be tested.”
Deshpande, A., Kawai, H., Metherate, R., Glabe, C. G., & Busciglio, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5980-08.2009 · Cited by 232
“5) (Snyder et al., 2005; Lacor et al., 2007), interaction with other proteins present at synapses such as apolipoprotein E or APP (Lorenzo et al., 2000; Sadowski et al., 2006), or disruption of insulin receptor signaling (Zhao et al., 2008).”
InfluentialHongpaisan, J., Sun, M.-K., & Alkon, D. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5209-10.2011 · Cited by 232
“A oligomers decrease synaptic transmission, reduce NMDA receptors in the postsynaptic membrane, reduce activity-dependent increases in intracellular Ca 2 , and increase protein phosphatase activity, resulting in synaptic loss (Snyder et al., 2005; Shankar et al., 2007).”
BackgroundAmyloid beta peptides and glutamatergic synaptic dysregulation
Parameshwaran, K., Dhanasekaran, M., & Suppiramaniam, V. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.008 · Cited by 235
Computational modeling of the effects of amyloid-beta on release probability at hippocampal synapses
Romani, A., Marchetti, C., Bianchi, D., Leinekugel, X., Poirazi, P., Migliore, M., & Marie, H. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00001 · Cited by 228
“Besides the acute effect on presynaptic release reported by Abramov et al. (2009), acute exposure to A β has also been shown to act at the postsynaptic terminal by reducing NMDA-mediated transmission (Snyder et al., 2005).”
BackgroundAmyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
Yankner, B. A., & Lu, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800018200 · Cited by 227
Hallett, P. J., Spoelgen, R., Hyman, B. T., Standaert, D. G., & Dunah, A. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0792-06.2006 · Cited by 225
“Recent studies have emphasized the importance of intracellular trafficking and synaptic clustering of NMDA receptor subunits as mechanisms to mediate synaptic plasticity (Grosshans et al., 2002; Wenthold et al., 2003; Snyder et al., 2005).”
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice
Chang, E. H., Savage, M. J., Flood, D. G., Thomas, J. M., Levy, R. B., Mahadomrongkul, V., Shirao, T., Aoki, C., & Huerta, P. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507313103 · Cited by 225
Botanical Phenolics and Brain Health
Sun, A. Y., Wang, Q., Simonyi, A., & Sun, G. Y. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8052-z · Cited by 223
“Although the mechanism for oligomeric Abeta to confer cytotoxicity that results in synaptic dysfunction is not clearly understood, there is evidence that these peptides can confer specific action on the N-methylD-aspartic acid (NMDA) receptors (Snyder et al. 2005).”
Kurup, P., Zhang, Y., Xu, J., Venkitaramani, D. V., Haroutunian, V., Greengard, P., Nairn, A. C., & Lombroso, P. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0157-10.2010 · Cited by 224
“Increased STEP protein levels are also found in human AD cor- tex. Results from our previous work found that the A -mediated reduced surface expression of NMDA receptor subunits is caused by increased endocytosis (Snyder et al., 2005).”
InfluentialSelf-citationCasein Kinase 2 Regulates the NR2 Subunit Composition of Synaptic NMDA Receptors
Sanz-Clemente, A., Matta, J. A., Isaac, J. T. R., & Roche, K. W. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.011 · Cited by 223
“These results are consistent with previous studies in which different stimuli that reduce Y1472 phosphorylation also decrease NR2B surface expression (Snyder et al., 2005; Zhang et al., 2008).”
Synaptic plasticity and phosphorylation
Lee, H.-K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.06.003 · Cited by 216
“Dephosphorylation mediates Abeta-dependent endocytosis (Snyder et al., 2005).”
Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice
Martinez-Coria, H., Green, K. N., Billings, L. M., Kitazawa, M., Albrecht, M., Rammes, G., Parsons, C. G., Gupta, S., Banerjee, P., & LaFerla, F. M. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090452 · Cited by 216
Naylor, D. E., Liu, H., Niquet, J., & Wasterlain, C. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.12.015 · Cited by 213
“, 2004), degenerative disorders (Chen et al., 1999c; Lau and Zukin, 2007; Snyder et al., 2005), and excitotoxicity/cell death (DeRidder et al.”
Kiyota, T., Okuyama, S., Swan, R. J., Jacobsen, M. T., Gendelman, H. E., & Ikezu, T. (2010) · The FASEB Journal · doi:10.1096/fj.10-155317 · Cited by 212
Picciotto, M. (2008) · Frontiers in Bioscience · doi:10.2741/2695 · Cited by 212
Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease
Mulder, J., Zilberter, M., Pasquaré, S. J., Alpár, A., Schulte, G., Ferreira, S. G., Köfalvi, A., Martín-Moreno, A. M., Keimpema, E., Tanila, H., et al. (2011) · Brain · doi:10.1093/brain/awr046 · Cited by 210
“Postsynaptic NMDA and AMPA receptors are widely viewed as key molecular targets of amyloid-b to disrupt synaptic plasticity (Kamenetz et al., 2003; Snyder et al., 2005; Shemer et al., 2006).”
InfluentialSun, B., Halabisky, B., Zhou, Y., Palop, J. J., Yu, G., Mucke, L., & Gan, L. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.10.003 · Cited by 205
“Our results also agree with the requirement of calcineurin for Ab-induced reduction in spines and in NMDA and AMPA receptors observed in cell or tissue cultures (Hsieh et al., 2006; Snyder et al., 2005a).”
Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects
Trejo, J., Piriz, J., Llorens-Martin, M. V., Fernandez, A. M., Bolós, M., LeRoith, D., Nuñez, A., & Torres-Aleman, I. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002076 · Cited by 210
Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease
Louneva, N., Cohen, J. W., Han, L.-Y., Talbot, K., Wilson, R. S., Bennett, D. A., Trojanowski, J. Q., & Arnold, S. E. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080434 · Cited by 210
Dysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors
Mota, S. I., Ferreira, I. L., & Rego, A. C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.013 · Cited by 206
“On the other hand, the decrease in NMDAR subunits may also be due to an increase in STEP 61 , which contributes to the endocytosis of GluN1/GluN2B and GluN1/GluN2A receptors (Snyder et al., 2005;Kurup et al., 2010).”
Linking glutamate receptor movements and synapse function
Groc, L., & Choquet, D. (2020) · Science · doi:10.1126/science.aay4631 · Cited by 207
“Alterations inNMDAR surface trafficking have also been reported in various models of neurological and psychiatric disorders, such as fragile X syndrome (96), Huntington’s disease (97), Alzheimer’s disease (98), and addiction (99).”
BackgroundThe synaptic Aβ hypothesis of Alzheimer disease
Tanzi, R. E. (2005) · Nature Neuroscience · doi:10.1038/nn0805-977 · Cited by 206
Co-Localization of Amyloid Beta and Tau Pathology in Alzheimer's Disease Synaptosomes
Fein, J. A., Sokolow, S., Miller, C. A., Vinters, H. V., Yang, F., Cole, G. M., & Gylys, K. H. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070829 · Cited by 204
“A synaptic A hypothesis is supported by data showing that A 42 binding to 7-nicotinic receptors induces N-methyl-D-aspartic acid (NMDA) receptor internalization and impaired glutamatergic transmission.(10) More recently, targeting of oligomer effects to NMDA receptors on dendritic spines have been suggested to promote…”
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease
Pereira, J. B., Janelidze, S., Ossenkoppele, R., Kvartsberg, H., Brinkmalm, A., Mattsson-Carlgren, N., Stomrud, E., Smith, R., Zetterberg, H., Blennow, K., et al. (2021) · Brain · doi:10.1093/brain/awaa395 · Cited by 203
“…trafficking has been shown to be a prime initial target for amyloid-b by several previous studies (Almeida et al., 2005; Roselli et al., 2005; Snyder et al., 2005; Shemer et al., 2006), suggesting that postsynaptic terminals might be more affected by amyloid pathology in early stages of…”
Majumder, S., Caccamo, A., Medina, D. X., Benavides, A. D., Javors, M. A., Kraig, E., Strong, R., Richardson, A., & Oddo, S. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00791.x · Cited by 203
“This finding is remarkable, as the reduced phosphorylation of NR2B at Tyr1472 correlates with receptor endocytosis, which leads to reduced NMDA receptor signaling (Snyder et al., 2005; Caccamo et al., 2010b).”
Calcium dysregulation in Alzheimer's disease
Bojarski, L., Herms, J., & Kuznicki, J. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.002 · Cited by 203
Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 202
“…that administration of A at low M concentrations (i.e., at concentrations higher than that used in the present work) can depress synaptic transmission by regulating glutamate receptors trafficking (Snyder et al., 2005; Tyszkiewicz and Yan, 2005; Hsieh et al., 2006; Parameshwaran et al., 2007).”
Fu, A. K. Y., Hung, K.-W., Huang, H., Gu, S., Shen, Y., Cheng, E. Y. L., Ip, F. C. F., Huang, X., Fu, W.-Y., & Ip, N. Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405803111 · Cited by 201
“Synaptic defects triggered by Aβ are mediated by the internalization and downregulation of both NMDA- and AMPA-type glutamate receptors (8, 9) together with a reduction of dendritic spines (6), where excitatory synapses are located.”
Agis-Torres, A., Sollhuber, M., Fernandez, M., & Sanchez-Montero, J. M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x113116660047 · Cited by 202
“Thus, there is a close relationship among A toxic oligomers and excessive activation of NMDA receptors with calcium influx, cPA2 activation, and oxidative/nitrosative aberrant signaling pathways, but also there is a direct influence of A oligomers as they act on NMDA receptor trafficking [82].”
Metabotropic NMDA receptor function is required for β-amyloid–induced synaptic depression
Kessels, H. W., Nabavi, S., & Malinow, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219605110 · Cited by 200
“In line with this scenario, the Aβ-dependent endocytosis of NMDARs requires phosphatase activity, and tyrosine dephosphorylation of GluN2B correlates with GluN1/GluN2B endocytosis (46, 47).”
How is protein aggregation in amyloidogenic diseases modulated by biological membranes?
Aisenbrey, C., Borowik, T., Byström, R., Bokvist, M., Lindström, F., Misiak, H., Sani, M.-A., & Gröbner, G. (2008) · European Biophysics Journal · doi:10.1007/s00249-007-0237-0 · Cited by 200
“However, recent work suggests an eVect on NMDA or AMPA receptors, residing at synaptic plasma membranes (Haass and Selkoe 2007; Snyder et al. 2005; Shankar et al. 2007).”
BackgroundInfluentialOligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism
Berman, D. E., Dall'Armi, C., Voronov, S. V., McIntire, L. B. J., Zhang, H., Moore, A. Z., Staniszewski, A., Arancio, O., Kim, T.-W., & Di Paolo, G. (2008) · Nature Neuroscience · doi:10.1038/nn.2100 · Cited by 199
“Consistent with these studies, oligomers of Aβ, particularly Aβ42, have been shown to directly affect synaptic plasticity and trigger the loss of synaptic dendritic spine”
ResultDziewczapolski, G., Glogowski, C. M., Masliah, E., & Heinemann, S. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6159-08.2009 · Cited by 198
“…the 7nAChR on neuronal cell surfaces, followed by endocytosis of the resulting complex and its accumulation within the lysosomal compartment (Nagele et al., 2002); and (5) synaptic transmission is impaired by A -dependent endocytosis of NMDA receptors after 7nAChR stimulation (Snyder et al., 2005).”
InfluentialResearch update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease
Parri, H. R., Hernandez, C. M., & Dineley, K. T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.039 · Cited by 187
Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function
Gladding, C. M., & Raymond, L. A. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.05.001 · Cited by 198
Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects
Frozza, R. L., Lourenco, M. V., & De Felice, F. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00037 · Cited by 198
“, 2011), impaired axonal transport (Snyder et al., 2005; Decker et al., 2010b; Miñano-Molina et al., 2011; Bomfim et al., 2012), and drive inhibition of long-term potentiation (LTP) and memory impairment (Rowan et al.”
BackgroundRegulation of NMDA receptors by the tyrosine kinase Fyn
Trepanier, C. H., Jackson, M. F., & MacDonald, J. F. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08391.x · Cited by 197
Life Extension Factor Klotho Prevents Mortality and Enhances Cognition in hAPP Transgenic Mice
Dubal, D. B., Zhu, L., Sanchez, P. E., Worden, K., Broestl, L., Johnson, E., Ho, K., Yu, G.-Q., Kim, D., Betourne, A., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.5791-12.2015 · Cited by 197
“, 2010), primary neurons treated with A (Snyder et al., 2005; Cissé et al., 2011; Li et al., 2011; Roberson et al., 2011; Zhang et al., 2011), and postmortem brain tissues from humans with AD (Sze et al.”
BackgroundCorreia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Candeias, E., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.063 · Cited by 195
Neurotrophins, synaptic plasticity and dementia
Arancio, O., & Chao, M. V. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.03.013 · Cited by 156
Impaired Spine Stability Underlies Plaque-Related Spine Loss in an Alzheimer's Disease Mouse Model
Spires-Jones, T. L., Meyer-Luehmann, M., Osetek, J. D., Jones, P. B., Stern, E. A., Bacskai, B. J., & Hyman, B. T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070055 · Cited by 189
“Recent work in cultured neurons strongly suggests that exposure of neurons to A causes endocytosis of glutamate receptors from the postsynaptic density in dendritic spines, which ultimately may destabilize the spines.(44,45) Involvement of A in synaptotoxic processes is further supported by a study showing that cleari…”
ResultMatta, J. A., Ashby, M. C., Sanz-Clemente, A., Roche, K. W., & Isaac, J. T. R. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.045 · Cited by 191
Zhang, Y., Venkitaramani, D. V., Gladding, C. M., Zhang, Y., Kurup, P., Molnar, E., Collingridge, G. L., & Lombroso, P. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2666-08.2008 · Cited by 191
“Inactive TAT-STEP [C/S] binds to its sub- strates and prevents their tyrosine dephosphorylation (Paul et al., 2003, 2007; Snyder et al., 2005).”
InfluentialSelf-citation
Metadata
- Authors
- Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Hospital for Sick Children (CA)
- Yale University (US)
- Cornell University (US)
- Corresponding author
- Snyder, Eric M
- Venue
- Nature Neuroscience
- Published
- 2005-07-17
- Volume
- 8
- Issue
- 8
- Pages
- 1051-1058
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1980750700
- Cited by
- 1,561
- References
- 41
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 54 · 2021: 80 · 2020: 75 · 2019: 52 · 2018: 70 · 2017: 74 · 2016: 78 · 2015: 81 · 2014: 89 · 2013: 91 · 2012: 97
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (01527, 52711)
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, NMDA receptor trafficking, receptor internalization, Alzheimer's disease, glutamatergic neurotransmission, synaptic plasticity, gamma-secretase inhibitors, alpha7 nicotinic acetylcholine receptor, calcineurin, synaptic dysfunction, cortical neurons
- MeSH terms
- Alzheimer Disease, Animals, Cell Membrane, Cerebral Cortex, Disease Models, Animal, Electric Conductivity, Endocytosis, Enzyme Activation, Neurons, Nuclear Proteins, Peptide Fragments, Receptors, Nicotinic, Synapses, Signal Transduction, Trans-Activators, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Tyrosine Phosphatases, Calcineurin, Protein Transport, CREB-Binding Protein, Mice, Protein Tyrosine Phosphatases, Non-Receptor, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.